{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Embelia ribes", "Embelin", "antitumor mechanisms", "bioavailability", "cancer", "toxicity of Embelin"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38234968", "DateRevised": {"Year": "2024", "Month": "01", "Day": "19"}, "Article": {"Language": ["eng"], "ELocationID": ["10.17179/excli2023-6590"], "ArticleDate": [{"Year": "2023", "Month": "12", "Day": "13"}], "Journal": {"ISSN": "1611-2156", "JournalIssue": {"Volume": "22", "PubDate": {"Year": "2023"}}, "Title": "EXCLI journal", "ISOAbbreviation": "EXCLI J"}, "ArticleTitle": "Embelin: A multifaceted anticancer agent with translational potential in targeting tumor progression and metastasis.", "Pagination": {"StartPage": "1311", "EndPage": "1329", "MedlinePgn": "1311-1329"}, "Abstract": {"AbstractText": ["Embelin, a natural para-benzoquinone product, is derived from plants of the Embelia genus, particularly <i>Embelia ribes</i> Burm.f. A staple in traditional medicinal formulations for centuries, Embelin's pharmacological actions are attributed to the hydroxyl benzoquinone present in its structure. Its therapeutic potential is bolstered by unique physical and chemical properties. Recently, Embelin, recognized as a non-peptidic, cell-permeable small inhibitor of the X-linked inhibitor of apoptosis protein (XIAP), has garnered significant attention for its anticancer activity. It demonstrates various anticancer mechanisms, such as apoptosis induction, cell cycle arrest, and autophagy, in different cancer types. Additionally, Embelin modulates several signal transduction pathways, including NF-\u03baB, PI3Kinase/AKT, and STAT3, effectively inhibiting the proliferation of diverse cancer cell lines. This literature review illuminates the anticancer potential of Embelin, detailing its mechanisms of action and prospective clinical applications, based on relevant scientific literature from the past decade sourced from various electronic databases. See also the Graphical abstract(Fig. 1)."], "CopyrightInformation": "Copyright \u00a9 2023 Kamath et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi-682 041, India."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutics, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi-682 041, India."}], "LastName": "Kamath", "ForeName": "Adithya Jayaprakash", "Initials": "AJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi-682 041, India."}], "LastName": "Chandy", "ForeName": "Alda Sara", "Initials": "AS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi-682 041, India."}], "LastName": "Joseph", "ForeName": "Aina Ann", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Wayne State University, Detroit-48202, Michigan, USA."}], "LastName": "Gorantla", "ForeName": "Jaggiah N", "Initials": "JN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi-682 041, India."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutics, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi-682 041, India."}], "LastName": "Donadkar", "ForeName": "Asawari Dilip", "Initials": "AD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi-682 041, India."}], "LastName": "Nath", "ForeName": "Lekshmi R", "Initials": "LR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Facultad de Medicina, Universidad del Azuay, Cuenca, Ecuador."}], "LastName": "Sharifi-Rad", "ForeName": "Javad", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania."}], "LastName": "Calina", "ForeName": "Daniela", "Initials": "D"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "EXCLI J", "NlmUniqueID": "101299402", "ISSNLinking": "1611-2156"}, "CoiStatement": "The authors wish to confirm that there are no known conflicts of interest associated with this publication, and there has been no significant financial support for this work that could have influenced its outcome."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Ahn KS, Sethi G, Aggarwal BB. Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks the nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products. Mol Pharmacol. 2007;71:209\u2013219. doi: 10.1124/mol.106.028787. doi: 10.1124/mol.106.028787. Available from:", "ArticleIdList": ["10.1124/mol.106.028787", "10.1124/mol.106.028787", "17028156"]}, {"Citation": "Alam MS, Damanhouri ZA, Ahmad A, Abidin L, Amir M, Aqil M, et al. Development of response surface methodology for optimization of extraction parameters and quantitative estimation of embelin from Embelia ribes Burm by high performance liquid chromatography. Pharmacogn Mag. 2015;11(Suppl 1):S166\u2013S172. doi: 10.4103/0973-1296.157722. doi: 10.4103/0973-1296.157722. Available from:", "ArticleIdList": ["10.4103/0973-1296.157722", "10.4103/0973-1296.157722", "PMC4461957", "26109763"]}, {"Citation": "Alimbetov D, Askarova S, Umbayev B, Davis T, Kipling D. Pharmacological targeting of cell cycle, apoptotic and cell adhesion signaling pathways implicated in chemoresistance of cancer cells. Int J Mol Sci. 2018;19(6):1690. doi: 10.3390/ijms19061690. doi: 10.3390/ijms19061690. Available from:", "ArticleIdList": ["10.3390/ijms19061690", "10.3390/ijms19061690", "PMC6032165", "29882812"]}, {"Citation": "B A, Fernandez A, Laila SP, Nair AS, Vishnu VS. Synthesis, characterization, molecular docking and anticancer studies of fluoroaniline derivatives of hydroxybenzoquinone and hydroxynaphthoquinone. J Biomol Struct Dyn. 2022;40:3917\u20133927. doi: 10.1080/07391102.2020.1852116. doi: 10.1080/07391102.2020.1852116. Available from:", "ArticleIdList": ["10.1080/07391102.2020.1852116", "10.1080/07391102.2020.1852116", "33314966"]}, {"Citation": "Basha NJ, Basavarajaiah SM, Baskaran S, Kumar P. A comprehensive insight on the biological potential of embelin and its derivatives. Nat Prod Res. 2022;36:3054\u20133068. doi: 10.1080/14786419.2021.1955361. doi: 10.1080/14786419.2021.1955361. Available from:", "ArticleIdList": ["10.1080/14786419.2021.1955361", "10.1080/14786419.2021.1955361", "34304655"]}, {"Citation": "Cao W, Li J, Yang K, Cao D. An overview of autophagy: Mechanism, regulation and research progress. Bull Cancer. 2021;108:304\u2013322. doi: 10.1016/j.bulcan.2020.11.004. doi: 10.1016/j.bulcan.2020.11.004. Available from:", "ArticleIdList": ["10.1016/j.bulcan.2020.11.004", "10.1016/j.bulcan.2020.11.004", "33423775"]}, {"Citation": "Chen J, Nikolovska-Coleska Z, Wang G, Qiu S, Wang S. Design, synthesis, and characterization of new embelin derivatives as potent inhibitors of X-linked inhibitor of apoptosis protein. Bioorg Med Chem Lett. 2006;16:5805\u20138. doi: 10.1016/j.bmcl.2006.08.072. doi: 10.1016/j.bmcl.2006.08.072. Available from:", "ArticleIdList": ["10.1016/j.bmcl.2006.08.072", "10.1016/j.bmcl.2006.08.072", "16962773"]}, {"Citation": "Dai Y, Desano J, Qu Y, Tang W, Meng Y, Lawrence TS, et al. Natural IAP inhibitor Embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer. Am J Cancer Res. 2011;1:128\u2013143.", "ArticleIdList": ["PMC3144474", "21804946"]}, {"Citation": "Dai Y, Jiao H, Teng G, Wang W, Zhang R, Wang Y, et al. Embelin reduces colitis-associated tumorigenesis through limiting IL-6/STAT3 signaling. Mol Cancer Ther. 2014;13:1206\u20131216. doi: 10.1158/1535-7163.MCT-13-0378. doi: 10.1158/1535-7163.MCT-13-0378. Available from:", "ArticleIdList": ["10.1158/1535-7163.MCT-13-0378", "10.1158/1535-7163.MCT-13-0378", "24651526"]}, {"Citation": "Dai Y, Qiao L, Chan KW, Yang M, Ye J, Ma J, et al. Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis. Cancer Res. 2009;69:4776\u20134783. doi: 10.1158/0008-5472.CAN-08-4754. doi: 10.1158/0008-5472.CAN-08-4754. Available from:", "ArticleIdList": ["10.1158/0008-5472.CAN-08-4754", "10.1158/0008-5472.CAN-08-4754", "19458067"]}, {"Citation": "Danquah M, Duke CB, 3rd, Patil R, Miller DD, Mahato RI. Combination therapy of antiandrogen and XIAP inhibitor for treating advanced prostate cancer. Pharm Res. 2012;29:2079\u20132091. doi: 10.1007/s11095-012-0737-1. doi: 10.1007/s11095-012-0737-1. Available from:", "ArticleIdList": ["10.1007/s11095-012-0737-1", "10.1007/s11095-012-0737-1", "22451249"]}, {"Citation": "Danquah M, Li F, Duke CB, 3rd, Miller DD, Mahato RI. Micellar delivery of bicalutamide and embelin for treating prostate cancer. Pharm Res. 2009;26:2081\u20132092. doi: 10.1007/s11095-009-9903-5. doi: 10.1007/s11095-009-9903-5. Available from:", "ArticleIdList": ["10.1007/s11095-009-9903-5", "10.1007/s11095-009-9903-5", "19415464"]}, {"Citation": "Das S, Shukla N, Singh SS, Kushwaha S, Shrivastava R. Mechanism of interaction between autophagy and apoptosis in cancer. Apoptosis. 2021;26:512\u2013533. doi: 10.1007/s10495-021-01687-9. doi: 10.1007/s10495-021-01687-9. Available from:", "ArticleIdList": ["10.1007/s10495-021-01687-9", "10.1007/s10495-021-01687-9", "34510317"]}, {"Citation": "Debela DT, Muzazu SG, Heraro KD, Ndalama MT, Mesele BW, Haile DC, et al. New approaches and procedures for cancer treatment: Current perspectives. SAGE Open Med. 2021;9:20503121211034366. doi: 10.1177/20503121211034366. doi: 10.1177/20503121211034366. Available from:", "ArticleIdList": ["10.1177/20503121211034366", "10.1177/20503121211034366", "PMC8366192", "34408877"]}, {"Citation": "Dhanjal JK, Nigam N, Sharma S, Chaudhary A, Kaul SC, Grover A, et al. Embelin inhibits TNF-\u03b1 converting enzyme and cancer cell metastasis: molecular dynamics and experimental evidence. BMC Cancer. 2014;14:775. doi: 10.1186/1471-2407-14-775. doi: 10.1186/1471-2407-14-775. Available from:", "ArticleIdList": ["10.1186/1471-2407-14-775", "10.1186/1471-2407-14-775", "PMC4210574", "25336399"]}, {"Citation": "Durg S, Veerapur VP, Neelima S, Dhadde SB. Antidiabetic activity of Embelia ribes, embelin and its derivatives: A systematic review and meta-analysis. Biomed Pharmacother. 2017;86:195\u2013204. doi: 10.1016/j.biopha.2016.12.001. doi: 10.1016/j.biopha.2016.12.001. Available from:", "ArticleIdList": ["10.1016/j.biopha.2016.12.001", "10.1016/j.biopha.2016.12.001", "27984799"]}, {"Citation": "Edderkaoui M, Lugea A, Hui H, Eibl G, Lu QY, Moro A, et al. Ellagic acid and embelin affect key cellular components of pancreatic adenocarcinoma, cancer, and stellate cells. Nutr Cancer. 2013;65:1232\u20131244. doi: 10.1080/01635581.2013.832779. doi: 10.1080/01635581.2013.832779. Available from:", "ArticleIdList": ["10.1080/01635581.2013.832779", "10.1080/01635581.2013.832779", "PMC3909533", "24127740"]}, {"Citation": "Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35:495\u2013516. doi: 10.1080/01926230701320337. doi: 10.1080/01926230701320337. Available from:", "ArticleIdList": ["10.1080/01926230701320337", "10.1080/01926230701320337", "PMC2117903", "17562483"]}, {"Citation": "Elwakeel A. Abrogating the interaction between p53 and mortalin (Grp75/HSPA9/mtHsp70) for cancer therapy: the story so far. Front Cell Dev Biol. 2022;10:879632. doi: 10.3389/fcell.2022.879632. doi: 10.3389/fcell.2022.879632. Available from:", "ArticleIdList": ["10.3389/fcell.2022.879632", "10.3389/fcell.2022.879632", "PMC9047732", "35493098"]}, {"Citation": "EU, European Commission. EU-funded projects for a cancer-free Europe! 2023.  Available from:  https://hadea.ec.europa.eu/news/eu-funded-projects-cancer-free-europe-2022-01-31_en."}, {"Citation": "Fu X, Pang X, Qi H, Chen S, Li Y, Tan W. XIAP inhibitor Embelin inhibits bladder cancer survival and invasion in vitro. Clin Transl Oncol. 2016;18:277\u2013282. doi: 10.1007/s12094-015-1363-2. doi: 10.1007/s12094-015-1363-2. Available from:", "ArticleIdList": ["10.1007/s12094-015-1363-2", "10.1007/s12094-015-1363-2", "26209051"]}, {"Citation": "Ghobrial IM, Witzig TE, Adjei AA. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin. 2005;55:178\u2013194. doi: 10.3322/canjclin.55.3.178. doi: 10.3322/canjclin.55.3.178. Available from:", "ArticleIdList": ["10.3322/canjclin.55.3.178", "10.3322/canjclin.55.3.178", "15890640"]}, {"Citation": "Government of India, Ministry of Health & Family Welfare. National programme for prevention & control of cancer, diabetes, cardiovascular diseases & stroke (NPCDCS) 2023.  Available from:  https://nhm.gov.in/index1.php?lang=1&level=2&sublinkid=1048&lid=604."}, {"Citation": "Gupta S, Sanyal SN. Biodistribution of embelin, a benzoquinone of male antifertility potential. Fitoterapia. 1991;62:419\u2013424."}, {"Citation": "Heo JY, Kim HJ, Kim SM, Park KR, Park SY, Kim SW, et al. Embelin suppresses STAT3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase PTEN. Cancer Lett. 2011;308(1):71\u201380. doi: 10.1016/j.canlet.2011.04.015. doi: 10.1016/j.canlet.2011.04.015. Available from:", "ArticleIdList": ["10.1016/j.canlet.2011.04.015", "10.1016/j.canlet.2011.04.015", "21565443"]}, {"Citation": "Hu R, Yang Y, Liu Z, Jiang H, Zhu K, Li J, et al. The XIAP inhibitor Embelin enhances TRAIL-induced apoptosis in human leukemia cells by DR4 and DR5 upregulation. Tumour Biol. 2015;36:769\u2013777. doi: 10.1007/s13277-014-2702-6. doi: 10.1007/s13277-014-2702-6. Available from:", "ArticleIdList": ["10.1007/s13277-014-2702-6", "10.1007/s13277-014-2702-6", "25293521"]}, {"Citation": "Hu R, Zhu K, Li Y, Yao K, Zhang R, Wang H, et al. Embelin induces apoptosis through down-regulation of XIAP in human leukemia cells. Med Oncol. 2011;28:1584\u20131588. doi: 10.1007/s12032-010-9601-5. doi: 10.1007/s12032-010-9601-5. Available from:", "ArticleIdList": ["10.1007/s12032-010-9601-5", "10.1007/s12032-010-9601-5", "20625944"]}, {"Citation": "Huang J, Ngai CH, Deng Y, Tin MS, Lok V, Zhang L, et al. Cancer incidence and mortality in Asian countries: a trend analysis. Cancer Control. 2022;29:10732748221095955. doi: 10.1177/10732748221095955. doi: 10.1177/10732748221095955. Available from:", "ArticleIdList": ["10.1177/10732748221095955", "10.1177/10732748221095955", "PMC9252010", "35770775"]}, {"Citation": "Huang M, Tang SN, Upadhyay G, Marsh JL, Jackman CP, Shankar S, et al. Embelin suppresses growth of human pancreatic cancer xenografts, and pancreatic cancer cells isolated from KrasG12D mice by inhibiting Akt and Sonic hedgehog pathways. PLoS One. 2014;9(4):e92161. doi: 10.1371/journal.pone.0092161. doi: 10.1371/journal.pone.0092161. Available from:", "ArticleIdList": ["10.1371/journal.pone.0092161", "10.1371/journal.pone.0092161", "PMC3973629", "24694877"]}, {"Citation": "Hussain AR, Siraj AK, Ahmed M, Bu R, Pratheeshkumar P, Alrashed AM, et al. XIAP over-expression is an independent poor prognostic marker in Middle Eastern breast cancer and can be targeted to induce efficient apoptosis. BMC Cancer. 2017;17(1):640. doi: 10.1186/s12885-017-3627-4. doi: 10.1186/s12885-017-3627-4. Available from:", "ArticleIdList": ["10.1186/s12885-017-3627-4", "10.1186/s12885-017-3627-4", "PMC5594504", "28893228"]}, {"Citation": "Isra\u00ebl A. The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb Perspect Biol. 2010;2(3):a000158. doi: 10.1101/cshperspect.a000158. doi: 10.1101/cshperspect.a000158. Available from:", "ArticleIdList": ["10.1101/cshperspect.a000158", "10.1101/cshperspect.a000158", "PMC2829958", "20300203"]}, {"Citation": "Jan R, Chaudhry GE. Understanding apoptosis and apoptotic pathways targeted cancer therapeutics. Adv Pharm Bull. 2019;9:205\u2013218. doi: 10.15171/apb.2019.024. doi: 10.15171/apb.2019.024. Available from:", "ArticleIdList": ["10.15171/apb.2019.024", "10.15171/apb.2019.024", "PMC6664112", "31380246"]}, {"Citation": "Jehan Z, Al-obaisi KA, Uddin S, Al-Kuraya K. Embelin induces autophagy in ovarian cancer cells. Cancer Res. 2012;72(8_Suppl):2265."}, {"Citation": "Jiang L, Hao JL, Jin ML, Zhang YG, Wei P. Effect of Embelin on TRAIL receptor 2 mAb-induced apoptosis of TRAIL-resistant A549 non-small cell lung cancer cells. Asian Pac J Cancer Prev. 2013;14:6115\u20136120. doi: 10.7314/apjcp.2013.14.10.6115. doi: 10.7314/apjcp.2013.14.10.6115. Available from:", "ArticleIdList": ["10.7314/apjcp.2013.14.10.6115", "10.7314/apjcp.2013.14.10.6115", "24289635"]}, {"Citation": "Kamble V, Attar U, Umdale S, Nimbalkar M, Ghane S, Gaikwad N. Phytochemical analysis, antioxidant activities and optimized extraction of embelin from different genotypes of Embelia ribes Burm f.: a woody medicinal climber from Western Ghats of India. Physiol Mol Biol Plants. 2020;26:1855\u20131865. doi: 10.1007/s12298-020-00859-2. doi: 10.1007/s12298-020-00859-2. Available from:", "ArticleIdList": ["10.1007/s12298-020-00859-2", "10.1007/s12298-020-00859-2", "PMC7468010", "32943821"]}, {"Citation": "Kim R. Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer. 2005;103:1551\u20131560. doi: 10.1002/cncr.20947. doi: 10.1002/cncr.20947. Available from:", "ArticleIdList": ["10.1002/cncr.20947", "10.1002/cncr.20947", "15742333"]}, {"Citation": "Ko JH, Lee SG, Yang WM, Um JY, Sethi G, Mishra S, et al. The application of embelin for cancer prevention and therapy. Molecules. 2018;23(3):621. doi: 10.3390/molecules23030621. doi: 10.3390/molecules23030621. Available from:", "ArticleIdList": ["10.3390/molecules23030621", "10.3390/molecules23030621", "PMC6017120", "29522451"]}, {"Citation": "Kocaturk NM, Akkoc Y, Kig C, Bayraktar O, Gozuacik D, Kutlu O. Autophagy as a molecular target for cancer treatment. Eur J Pharm Sci. 2019;134:116\u2013137. doi: 10.1016/j.ejps.2019.04.011. doi: 10.1016/j.ejps.2019.04.011. Available from:", "ArticleIdList": ["10.1016/j.ejps.2019.04.011", "10.1016/j.ejps.2019.04.011", "30981885"]}, {"Citation": "Kundap UP, Bhuvanendran S, Kumari Y, Othman I, Shaikh MF. Plant derived phytocompound, embelin in cns disorders: a systematic review. Front Pharmacol. 2017;8:76. doi: 10.3389/fphar.2017.00076. doi: 10.3389/fphar.2017.00076. Available from:", "ArticleIdList": ["10.3389/fphar.2017.00076", "10.3389/fphar.2017.00076", "PMC5326771", "28289385"]}, {"Citation": "Lee YJ, Park BS, Park HR, Yu SB, Kang HM, Kim IR. XIAP inhibitor embelin induces autophagic and apoptotic cell death in human oral squamous cell carcinoma cells. Environ Toxicol. 2017;32:2371\u20132378. doi: 10.1002/tox.22450. doi: 10.1002/tox.22450. Available from:", "ArticleIdList": ["10.1002/tox.22450", "10.1002/tox.22450", "PMC6472881", "28722333"]}, {"Citation": "Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer. Mol Cancer. 2020;19(1):12. doi: 10.1186/s12943-020-1138-4. doi: 10.1186/s12943-020-1138-4. Available from:", "ArticleIdList": ["10.1186/s12943-020-1138-4", "10.1186/s12943-020-1138-4", "PMC6975070", "31969156"]}, {"Citation": "Li Z, Chen SJ, Yu XA, Li J, Gao XM, He J, et al. Pharmacokinetic and bioavailability studies of embelin after intravenous and oral administration to rats. Evid Based Complement Alternat Med. 2019;2019:9682495. doi: 10.1155/2019/9682495. doi: 10.1155/2019/9682495. Available from:", "ArticleIdList": ["10.1155/2019/9682495", "10.1155/2019/9682495", "PMC6446108", "31015855"]}, {"Citation": "Liang YH, Wu JM, Teng JW, Hung E, Wang HS. Embelin downregulated cFLIP in breast cancer cell lines facilitate anti-tumor effect of IL-1\u03b2-stimulated human umbilical cord mesenchymal stem cells. Sci Rep. 2021;11(1):14720. doi: 10.1038/s41598-021-94006-w. doi: 10.1038/s41598-021-94006-w. Available from:", "ArticleIdList": ["10.1038/s41598-021-94006-w", "10.1038/s41598-021-94006-w", "PMC8289868", "34282169"]}, {"Citation": "Lim KH, Staudt LM. Toll-like receptor signaling. Cold Spring Harb Perspect Biol. 2013;5(1):a011247. doi: 10.1101/cshperspect.a011247. doi: 10.1101/cshperspect.a011247. Available from:", "ArticleIdList": ["10.1101/cshperspect.a011247", "10.1101/cshperspect.a011247", "PMC3579400", "23284045"]}, {"Citation": "Militello RD, Colombo MI. A membrane is born: origin of the autophagosomal compartment. Curr Mol Med. 2011;11:197\u2013203. doi: 10.2174/156652411795243441. doi: 10.2174/156652411795243441. Available from:", "ArticleIdList": ["10.2174/156652411795243441", "10.2174/156652411795243441", "21375493"]}, {"Citation": "Mizukami J, Takaesu G, Akatsuka H, Sakurai H, Ninomiya-Tsuji J, Matsumoto K, et al. Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6. Mol Cell Biol. 2002;22:992\u20131000. doi: 10.1128/MCB.22.4.992-1000.2002. doi: 10.1128/MCB.22.4.992-1000.2002. Available from:", "ArticleIdList": ["10.1128/MCB.22.4.992-1000.2002", "10.1128/MCB.22.4.992-1000.2002", "PMC134634", "11809792"]}, {"Citation": "Modak R, Basha J, Bharathy N, Maity K, Mizar P, Bhat AV, et al. Probing p300/CBP associated factor (PCAF)-dependent pathways with a small molecule inhibitor. ACS Chem Biol. 2013;8:1311\u20131323. doi: 10.1021/cb4000597. doi: 10.1021/cb4000597. Available from:", "ArticleIdList": ["10.1021/cb4000597", "10.1021/cb4000597", "23570531"]}, {"Citation": "Morana O, Wood W, Gregory CD. The apoptosis paradox in cancer. Int J Mol Sci. 2022;23(3):1328. doi: 10.3390/ijms23031328. doi: 10.3390/ijms23031328. Available from:", "ArticleIdList": ["10.3390/ijms23031328", "10.3390/ijms23031328", "PMC8836235", "35163253"]}, {"Citation": "Morel E, Mehrpour M, Botti J, Dupont N, Hama\u00ef A, Nascimbeni AC, et al. Autophagy: a druggable process. Annu Rev Pharmacol Toxicol. 2017;57:375\u2013398. doi: 10.1146/annurev-pharmtox-010716-104936. doi: 10.1146/annurev-pharmtox-010716-104936. Available from:", "ArticleIdList": ["10.1146/annurev-pharmtox-010716-104936", "10.1146/annurev-pharmtox-010716-104936", "28061686"]}, {"Citation": "Nigam N, Grover A, Goyal S, Katiyar SP, Bhargava P, Wang PC, et al. Targeting mortalin by embelin causes activation of tumor suppressor p53 and deactivation of metastatic signaling in human breast cancer cells. PLoS One. 2015;10(9):e0138192. doi: 10.1371/journal.pone.0138192. doi: 10.1371/journal.pone.0138192. Available from:", "ArticleIdList": ["10.1371/journal.pone.0138192", "10.1371/journal.pone.0138192", "PMC4574062", "26376435"]}, {"Citation": "Onorati AV, Dyczynski M, Ojha R, Amaravadi RK. Targeting autophagy in cancer. Cancer. 2018;124:3307\u20133318. doi: 10.1002/cncr.31335. doi: 10.1002/cncr.31335. Available from:", "ArticleIdList": ["10.1002/cncr.31335", "10.1002/cncr.31335", "PMC6108917", "29671878"]}, {"Citation": "Othman SNN, Lum PT, Sekar M, Mazlan NA, Yusri PZ, Ghazali NF, et al. Molecules of interest -embelin -a review. Res J Pharm Technol. 2020;13:3485\u20133493. doi: 10.5958/0974-360X.2020.00618.6. doi: 10.5958/0974-360X.2020.00618.6. Available from:", "ArticleIdList": ["10.5958/0974-360X.2020.00618.6", "10.5958/0974-360X.2020.00618.6"]}, {"Citation": "Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71. doi: 10.1136/bmj.n71. Available from:", "ArticleIdList": ["10.1136/bmj.n71", "10.1136/bmj.n71", "PMC8005924", "33782057"]}, {"Citation": "Park N, Baek HS, Chun YJ. Embelin-induced apoptosis of human prostate cancer cells is mediated through modulation of akt and \u03b2-catenin signaling. PLoS One. 2015;10(8):e0134760. doi: 10.1371/journal.pone.0134760. doi: 10.1371/journal.pone.0134760. Available from:", "ArticleIdList": ["10.1371/journal.pone.0134760", "10.1371/journal.pone.0134760", "PMC4529160", "26252009"]}, {"Citation": "Peng M, Huang B, Zhang Q, Fu S, Wang D, Cheng X, et al. Embelin inhibits pancreatic cancer progression by directly inducing cancer cell apoptosis and indirectly restricting IL-6 associated inflammatory and immune suppressive cells. Cancer Lett. 2014;354:407\u2013416. doi: 10.1016/j.canlet.2014.08.011. doi: 10.1016/j.canlet.2014.08.011. Available from:", "ArticleIdList": ["10.1016/j.canlet.2014.08.011", "10.1016/j.canlet.2014.08.011", "25128650"]}, {"Citation": "Pfeffer CM, Singh ATK. Apoptosis: a target for anticancer therapy. Int J Mol Sci. 2018;19(2):448. doi: 10.3390/ijms19020448. doi: 10.3390/ijms19020448. Available from:", "ArticleIdList": ["10.3390/ijms19020448", "10.3390/ijms19020448", "PMC5855670", "29393886"]}, {"Citation": "Podolak I, Galanty A, Janeczko Z. Cytotoxic activity of embelin from Lysimachia punctata. Fitoterapia. 2005;76:333\u2013335. doi: 10.1016/j.fitote.2005.02.006. doi: 10.1016/j.fitote.2005.02.006. Available from:", "ArticleIdList": ["10.1016/j.fitote.2005.02.006", "10.1016/j.fitote.2005.02.006", "15890461"]}, {"Citation": "Poojari R. Embelin\u2013a drug of antiquity: shifting the paradigm towards modern medicine. Exp Opin Invest Drugs. 2014;23:427\u2013444.", "ArticleIdList": ["24397264"]}, {"Citation": "Prabhu KS, Siveen KS, Kuttikrishnan S, Iskandarani A, Tsakou M, Achkar IW, et al. Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells. PLoS One. 2017;12(7):e0180895. doi: 10.1371/journal.pone.0180895. doi: 10.1371/journal.pone.0180895. Available from:", "ArticleIdList": ["10.1371/journal.pone.0180895", "10.1371/journal.pone.0180895", "PMC5509148", "28704451"]}, {"Citation": "Qian H, Huang T, Chen Y, Li X, Gong W, Jiang G, et al. X-linked inhibitor of apoptosis protein inhibitor Embelin induces apoptosis via PI3K/Akt pathway and inhibits invasion in osteosarcoma cells. J Cancer Res Ther. 2018;14(Suppl):S648\u2013S655. doi: 10.4103/0973-1482.203599. doi: 10.4103/0973-1482.203599. Available from:", "ArticleIdList": ["10.4103/0973-1482.203599", "10.4103/0973-1482.203599", "30249882"]}, {"Citation": "Rahman MA, Hannan MA, Dash R, Rahman MH, Islam R, Uddin MJ, et al. Phytochemicals as a complement to cancer chemotherapy: pharmacological modulation of the autophagy-apoptosis pathway. Front Pharmacol. 2021;12:639628. doi: 10.3389/fphar.2021.639628. doi: 10.3389/fphar.2021.639628. Available from:", "ArticleIdList": ["10.3389/fphar.2021.639628", "10.3389/fphar.2021.639628", "PMC8138161", "34025409"]}, {"Citation": "Russell RC, Yuan HX, Guan KL. Autophagy regulation by nutrient signaling. Cell Res. 2014;24(1):42\u201357. doi: 10.1038/cr.2013.166. doi: 10.1038/cr.2013.166. Available from:", "ArticleIdList": ["10.1038/cr.2013.166", "10.1038/cr.2013.166", "PMC3879708", "24343578"]}, {"Citation": "Schwartz GK, Shah MA. Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol. 2005;23:9408\u20139421. doi: 10.1200/JCO.2005.01.5594. doi: 10.1200/JCO.2005.01.5594. Available from:", "ArticleIdList": ["10.1200/JCO.2005.01.5594", "10.1200/JCO.2005.01.5594", "16361640"]}, {"Citation": "Senese S, Lo YC, Huang D, Zangle TA, Gholkar AA, Robert L, et al. Chemical dissection of the cell cycle: probes for cell biology and anti-cancer drug development. Cell Death Dis. 2014;5(10):e1462. doi: 10.1038/cddis.2014.420. doi: 10.1038/cddis.2014.420. Available from:", "ArticleIdList": ["10.1038/cddis.2014.420", "10.1038/cddis.2014.420", "PMC4237247", "25321469"]}, {"Citation": "Sharma V, Gautam DNS, Radu AF, Behl T, Bungau SG, Vesa CM. Reviewing the traditional/modern uses, phytochemistry, essential oils/extracts and pharmacology of Embelia ribes Burm. Antioxidants (Basel) 2022;11(7):1359. doi: 10.3390/antiox11071359. doi: 10.3390/antiox11071359. Available from:", "ArticleIdList": ["10.3390/antiox11071359", "10.3390/antiox11071359", "PMC9311956", "35883850"]}, {"Citation": "Siegelin MD, Gaiser T, Siegelin Y. The XIAP inhibitor Embelin enhances TRAIL-mediated apoptosis in malignant glioma cells by down-regulation of the short isoform of FLIP. Neurochem Int. 2009;55:423\u2013430. doi: 10.1016/j.neuint.2009.04.011. doi: 10.1016/j.neuint.2009.04.011. Available from:", "ArticleIdList": ["10.1016/j.neuint.2009.04.011", "10.1016/j.neuint.2009.04.011", "19409438"]}, {"Citation": "Singh S, Sharma B, Kanwar SS, Kumar A. Lead phytochemicals for anticancer drug development. Front Plant Sci. 2016;7:1667. doi: 10.3389/fpls.2016.01667. doi: 10.3389/fpls.2016.01667. Available from:", "ArticleIdList": ["10.3389/fpls.2016.01667", "10.3389/fpls.2016.01667", "PMC5099879", "27877185"]}, {"Citation": "Soubannier V, Stifani S. NF-\u03baB signalling in glioblastoma. Biomedicines. 2017;5(2):29. doi: 10.3390/biomedicines5020029. doi: 10.3390/biomedicines5020029. Available from:", "ArticleIdList": ["10.3390/biomedicines5020029", "10.3390/biomedicines5020029", "PMC5489815", "28598356"]}, {"Citation": "Sreepriya M, Bali G. Chemopreventive effects of embelin and curcumin against N-nitrosodiethylamine/phenobarbital-induced hepatocarcinogenesis in Wistar rats. Fitoterapia. 2005;76:549\u2013555. doi: 10.1016/j.fitote.2005.04.014. doi: 10.1016/j.fitote.2005.04.014. Available from:", "ArticleIdList": ["10.1016/j.fitote.2005.04.014", "10.1016/j.fitote.2005.04.014", "16009505"]}, {"Citation": "Srinivas K. Anticancer and antimicrobial activity of embelin derivatives. Int J Preclin Pharmacol Res. 2010;1(1):35\u20138."}, {"Citation": "Srinivas N, Narsimha Reddy Y, Goverdhan P, Venkateshwarlu K. Development and validation of HPLC method for determination of Embelin in rat plasma and its application to pharmacokinetic study. J Pharm Res. 2011;4:3660\u20133663."}, {"Citation": "Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u2013249. doi: 10.3322/caac.21660. doi: 10.3322/caac.21660. Available from:", "ArticleIdList": ["10.3322/caac.21660", "10.3322/caac.21660", "33538338"]}, {"Citation": "United Nations. 11th High level meeting on prevention and control of non-communicable diseases. 2011.  [April 3, 2023].  Available from:  http://www.un.org/en/ga/ncdmeeting2011/"}, {"Citation": "Vijayan KPR, Raghu AV. Embelin: an HPTLC method for quantitative estimation in five species of genus Embelia Burm. f. Futur J Pharm Sci. 2021;7:55. doi: 10.1186/s43094-021-00210-w. doi: 10.1186/s43094-021-00210-w. Available from:", "ArticleIdList": ["10.1186/s43094-021-00210-w", "10.1186/s43094-021-00210-w"]}, {"Citation": "Wang A, Zhang B, Zhang J, Wu W, Wu W. Embelin-induced brain glioma cell apoptosis and cell cycle arrest via the mitochondrial pathway. Oncol Rep. 2013;29:2473\u20132478. doi: 10.3892/or.2013.2369. doi: 10.3892/or.2013.2369. Available from:", "ArticleIdList": ["10.3892/or.2013.2369", "10.3892/or.2013.2369", "23545899"]}, {"Citation": "Wang DG, Sun YB, Ye F, Li W, Kharbuja P, Gao L, et al. Anti-tumor activity of the X-linked inhibitor of apoptosis (XIAP) inhibitor embelin in gastric cancer cells. Mol Cell Biochem. 2014;386:143\u2013152. doi: 10.1007/s11010-013-1853-x. doi: 10.1007/s11010-013-1853-x. Available from:", "ArticleIdList": ["10.1007/s11010-013-1853-x", "10.1007/s11010-013-1853-x", "24136460"]}, {"Citation": "Wijdeven RH, Janssen H, Nahidiazar L, Janssen L, Jalink K, Berlin I, et al. Cholesterol and ORP1L-mediated ER contact sites control autophagosome transport and fusion with the endocytic pathway. Nat Commun. 2016;7:11808. doi: 10.1038/ncomms11808. doi: 10.1038/ncomms11808. Available from:", "ArticleIdList": ["10.1038/ncomms11808", "10.1038/ncomms11808", "PMC4906411", "27283760"]}, {"Citation": "Xu M, Cui J, Fu H, Proksch P, Lin W, Li M. Embelin derivatives and their anticancer activity through microtubule disassembly. Planta Med. 2005;71:944\u2013948. doi: 10.1055/s-2005-871250. doi: 10.1055/s-2005-871250. Available from:", "ArticleIdList": ["10.1055/s-2005-871250", "10.1055/s-2005-871250", "16254827"]}, {"Citation": "Yang Y, Zheng L, Zheng X, Ge L. Autophagosomal membrane origin and formation. Adv Exp Med Biol. 2021;1208:17\u201342. doi: 10.1007/978-981-16-2830-6_2. doi: 10.1007/978-981-16-2830-6_2. Available from:", "ArticleIdList": ["10.1007/978-981-16-2830-6_2", "10.1007/978-981-16-2830-6_2", "34260019"]}, {"Citation": "Yun CW, Lee SH. The roles of autophagy in cancer. Int J Mol Sci. 2018;19(11):3466. doi: 10.3390/ijms19113466. doi: 10.3390/ijms19113466. Available from:", "ArticleIdList": ["10.3390/ijms19113466", "10.3390/ijms19113466", "PMC6274804", "30400561"]}, {"Citation": "Zutshi U, Sharma SC, Kaul JL, Atal CK. Kinetic fate of potassium embelate, a non-narcotic centrally acting analgesic after oral and intravenous administration. Pharmacology. 1990;40:179\u2013184. doi: 10.1159/000138. doi: 10.1159/000138. Available from:", "ArticleIdList": ["10.1159/000138", "10.1159/000138", "2333322"]}]}], "History": [{"Year": "2023", "Month": "9", "Day": "12"}, {"Year": "2023", "Month": "11", "Day": "23"}, {"Year": "2024", "Month": "1", "Day": "18", "Hour": "6", "Minute": "44"}, {"Year": "2024", "Month": "1", "Day": "18", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "1", "Day": "18", "Hour": "4", "Minute": "16"}, {"Year": "2023", "Month": "12", "Day": "13"}], "PublicationStatus": "epublish", "ArticleIdList": ["38234968", "PMC10792175", "10.17179/excli2023-6590", "2023-6590"]}}]}